1129205

Leading Pharma, LLC — FEI 3001611969

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 11, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fairfield, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)